AIM IMMUNOTECH INC. Increase (Decrease) in Other Receivables
AIM IMMUNOTECH INC. (AIM) reported Increase (Decrease) in Other Receivables of -$7.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-07
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for the quarter ending 2026-06-30 was $0.00.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was -$7.00K, a 136.84% decline year-over-year.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for the quarter ending 2025-03-31 was $19.00K.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for the quarter ending 2023-09-30 was $1.69M.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for fiscal 2025 was $7.00K.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for fiscal 2022 was $35.00K, a 93.65% decline from fiscal 2021.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for fiscal 2021 was $551.00K, a 75.48% increase from fiscal 2020.
- AIM IMMUNOTECH INC. increase (decrease) in other receivables for fiscal 2020 was $314.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$7.00K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | -$7.00K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $7.00K 10-K · filed 2026-03-27 | |||
| 2025-03-31 | $19.00K 10-Q · filed 2026-05-15 | |||
| 2023-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $9.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$1.68M 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.68M derived: sum of 2 quarters · filed 2023-03-31 | $35.00K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.64M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$1.64M 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.64M derived: sum of 2 quarters · filed 2023-03-31 | $551.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.09M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$1.09M 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.08M derived: sum of 2 quarters · filed 2022-03-31 | $314.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$776.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$770.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |